Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 31.05
0.00 (0.00%)
At close: Mar 26, 2026
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 15.57 billion as of March 26, 2026. Its market cap has increased by 11.77% in one year.
Market Cap
15.57B
Enterprise Value
17.47B
Revenue
6.11B
Ranking
n/a
PE Ratio
19.66
Stock Price
31.05
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 15.57B, an increase of 2,568.60%. That is a compound annual growth rate of 17.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 15.57B | -4.17% |
| Dec 31, 2025 | 16.25B | 12.06% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 30.68B |
| TTY Biopharm Company | 19.69B |
| Grape King Bio | 17.63B |
| ScinoPharm Taiwan | 16.45B |
| YungShin Global Holding | 13.85B |
| Foresee Pharmaceuticals | 12.10B |
| Standard Chemical & Pharmaceutical | 11.06B |
| Alar Pharmaceuticals | 11.06B |